Yantai Zestern Biotechnique Co. LTD, Yantai, Shandong, 264670, China.
Department of Nutrition, University of Tennessee at Knoxville, 229 Jessie Harris Building, 1215 West Cumberland Avenue, Knoxville, TN, 37909, USA.
Glob Health Res Policy. 2022 May 11;7(1):13. doi: 10.1186/s41256-022-00247-1.
Diabetes, a global health concern, requires insulin therapy. As insulin demand and prices rise dramatically, insulin affordability has increasingly become an issue facing patients with diabetes worldwide. To cut insulin costs, many patients ration their supply, which may have dire health consequences. This particularly affects lower-income populations, who are often forced to choose between purchasing their medications or paying for other necessities. Nutrition might be one solution for this. This commentary aims to provide comprehensive insight with historical context into intersectional components of diabetes in the global arena through analyses of insulin affordability, coupled with the critical role of nutrition intervention after searching the PubMed for relevant articles. More studies in personalized nutrition, supplementations, and dietary behaviors may develop evidence-based nutrition interventions to control diabetes. We argue that alongside price regulation, a greater focus to nutrition to address issues of food insecurity and food assistance programs may help to improve insulin affordability.
糖尿病是一个全球性的健康问题,需要胰岛素治疗。随着胰岛素需求和价格的急剧上升,胰岛素的可负担性越来越成为全球糖尿病患者面临的一个问题。为了降低胰岛素的成本,许多患者会定量配给胰岛素,这可能会带来严重的健康后果。这尤其影响到低收入人群,他们经常不得不在购买药物或支付其他生活必需品之间做出选择。营养可能是解决这个问题的一个方法。本评论旨在通过分析胰岛素的可负担性,并结合营养干预的关键作用,从历史背景的角度提供一个全面的观点,以了解全球糖尿病的交叉性因素。通过搜索 PubMed 中的相关文章,更多关于个性化营养、补充剂和饮食行为的研究可能会制定出基于证据的营养干预措施来控制糖尿病。我们认为,除了价格监管外,更多地关注营养问题,以解决粮食不安全和粮食援助计划问题,可能有助于提高胰岛素的可负担性。